English
Back
Download
Log in to access Online Inquiry
Back to the Top

News

$Replimune (REPL.US)$ Reuters· 3 mins ago
Replimune Receives Breakthrough Therapy Designation for Rp1 and Submits Rp1 Biologics License Application to the FDA Under the Accelerated Approval Pathway
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only. Read more
Translate
Report
5103 Views
Comment
Sign in to post a comment
    5121
    Followers
    23
    Following
    74K
    Visitors
    Follow
    Reassessing Chinese Assets
    Following the introduction of China's groundbreaking DeepSeek technology, Wall Street giants have revised their investment outlooks for the Chinese market.